NCT03126916 2026-02-27Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)Children's Oncology GroupPhase 3 Recruiting750 enrolled
NCT01704716 2020-10-23High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN)St. Anna KinderkrebsforschungPhase 3 Recruiting3,300 enrolled